Physiologic Jaundice in Newborns – A Complete Medical Guide
Overview
Physiologic jaundice (also called “normal” or “benign” jaundice) is a common, usually harmless rise in the level of bilirubin in a newborn’s blood during the first week of life. Bilirubin is a yellow pigment produced when red blood cells break down. In healthy newborns the liver is not yet fully mature and cannot process bilirubin as quickly as older infants, leading to a temporary yellow‑tinged discoloration of the skin and whites of the eyes.
- Population affected: Virtually all full‑term infants and many preterm babies experience some degree of physiologic jaundice.
- Prevalence: Up to 60 % of term infants and 80 % of preterm infants develop visible jaundice within the first week.[1] Mayo Clinic
- Typical timing: Begins 2–3 days after birth, peaks around day 4–5, and usually resolves by 1–2 weeks in term infants and by 3–4 weeks in preterm infants.
Symptoms
Physiologic jaundice presents with a characteristic pattern of yellow discoloration that follows the progression of bilirubin through the body. The following signs are typical:
Skin discoloration
- Head and face first: The forehead, cheeks, and neck turn yellow.
- Trunk and abdomen: The yellow spreads to the chest and abdomen as bilirubin levels rise.
- Extremities: In more pronounced cases the arms, legs, and even the soles of the feet become yellow.
Eye changes
- Scleral icterus: The whites of the eyes (sclera) develop a yellow hue; this is often the earliest objective sign.
Feeding and behavior
- Usually normal, but some babies may be slightly more sleepy or fussy if bilirubin is high.
Other physical findings
- No rash, bruising, or swelling.
- Normal heart rate, breathing, and temperature.
Note: Because physiologic jaundice is a diagnosis of exclusion, any additional symptoms such as fever, poor feeding, lethargy, high‑pitched crying, or a bulging fontanelle should prompt immediate evaluation for other causes.
Causes and Risk Factors
Physiologic jaundice is caused by a combination of normal newborn physiology and certain perinatal factors.
Underlying mechanisms
- Increased bilirubin production: Newborns have a higher red‑cell turnover (about 5 % of total red cells per day) compared with adults.
- Immature hepatic conjugation: The enzyme uridine diphosphate glucuronosyltransferase (UGT1A1) responsible for turning bilirubin water‑soluble is under‑developed in the first days of life.
- Reduced enterohepatic circulation: In the first few days, newborns absorb some bilirubin that is excreted into the intestines and then re‑absorbed, raising serum levels.
Risk factors that increase the likelihood or severity
- Pre‑term birth (< 37 weeks gestation) – liver immaturity is greater.
- Birth weight < 2500 g (low‑birth‑weight infants).
- Breastfeeding challenges – inadequate milk intake in the first 48 h can slow bilirubin excretion (also called “breast‑feeding jaundice”).
- Bruising or cephalohematoma from delivery – extra red‑cell breakdown adds bilirubin.
- East Asian ancestry – higher baseline UGT1A1 activity.
- Maternal diabetes or a prolonged labor – can lead to higher neonatal red‑cell mass.
- Sibling with severe jaundice or known G6PD deficiency.
Diagnosis
Diagnosis is clinical but must be confirmed and monitored with laboratory testing to ensure bilirubin remains within the safe range for the infant’s age and risk profile.
Physical examination
- Visual inspection of skin and sclera for icterus.
- Assessment of hydration (wet diapers, weight loss < 10 %).
- Check for signs of hemolysis (pallor, enlarged spleen).
Laboratory tests
- Serum total bilirubin (TsB): Primary test; measured in mg/dL. A “transcutaneous bilirubinometer” may be used for quick screening, but a serum sample is required for treatment decisions.
- Direct (conjugated) bilirubin: Helps rule out pathologic causes (levels > 0.2 mg/dL in term infants suggest cholestasis).
- Complete blood count (CBC) & reticulocyte count: Detects hemolytic anemia.
- Blood type and Coombs test: Looks for ABO or Rh incompatibility.
- G6PD assay: In populations at risk for enzymatic deficiency.
Risk‑based nomograms
Clinicians use age‑specific bilirubin nomograms (Bhutani chart) that stratify infants into low, intermediate, or high risk zones. These charts are endorsed by the American Academy of Pediatrics (AAP) and guide decisions about phototherapy or hospitalization.[2] AAP Guidelines
Treatment Options
Most cases of physiologic jaundice resolve without intervention, but treatment is aimed at keeping bilirubin below neurotoxic thresholds.
Phototherapy
- How it works: Blue‑green light (≈460 nm) converts unconjugated bilirubin into water‑soluble isomers that can be excreted without liver conjugation.
- Indications: TsB ≥ 12 mg/dL in a term infant < 72 h old, or per risk‑based nomogram. Preterm infants have lower thresholds.
- Types: Overhead lamps, fiber‑optic blankets, or LED phototherapy units.
- Duration: Usually 6–24 hours; repeat testing guides discontinuation.
Exchange transfusion
Rarely needed for physiologic jaundice; reserved for bilirubin levels > 25 mg/dL in term infants or > 20 mg/dL in preterm infants when rapid reduction is essential to prevent kernicterus.
Optimizing feeding
- Encourage frequent (8–12 times/day) breastfeeding or formula feeds to promote stooling and bilirubin excretion.
- Monitor weight; a loss > 10 % of birth weight warrants assessment.
Supplemental treatments
- IV fluids: In cases of dehydration.
- Phenobarbital: Occasionally used to boost UGT1A1 activity, but not routine for physiologic jaundice.
Home care measures
- Expose baby to indirect sunlight for short periods (10‑15 min) while avoiding overheating—effective only for mild jaundice.
- Maintain a warm, well‑ventilated environment.
Living with a Jaundiced Newborn (Physiologic Jaundice)
While your baby may look yellow, most families can manage the condition at home with careful monitoring.
Feeding tips
- Breastfeed at least 8–12 times in 24 h; if milk supply is a concern, consider lactation consultant support.
- If breastfeeding isn’t possible, fortified formula is an alternative.
- Track diaper output: ≥ 6 wet diapers and ≥ 3 yellow, seedy stools per day.
Monitoring bilirubin
- Ask your pediatrician for a follow‑up bilirubin test 24‑48 h after discharge if the initial level was borderline.
- Keep a log of feeding times, diaper counts, weight (if you have a scale), and any changes in skin color.
Bathing and skin care
- Use lukewarm water; avoid harsh soaps that could dry the newborn’s skin.
- Do not rub the baby’s skin vigorously—gentle patting is sufficient.
Sleep and positioning
- Place the infant on their back (supine) for sleep to reduce SIDS risk.
- Re‑position frequently to avoid pressure points and promote circulation.
When to call the pediatrician
- Bilirubin level rises faster than expected (e.g., > 0.2 mg/dL per hour).
- Feeding becomes difficult, weight loss exceeds 10 %.
- New symptoms appear (fever, vomiting, lethargy).
Prevention
Because physiologic jaundice stems from normal newborn processes, it cannot be entirely prevented, but several strategies reduce its severity and the need for treatment.
- Early and frequent feeding: Initiate breastfeeding within the first hour after birth when possible.
- Monitor weight loss: Keep loss under 10 % of birth weight in the first week.
- Educate parents: Teach how to recognize jaundice and the importance of regular diaper output.
- Manage risk in at‑risk groups: For preterm or low‑birth‑weight infants, consider earlier bilirubin screening (24 h) and possibly prophylactic phototherapy in NICU settings.
- Prevent hemolysis: Proper handling during delivery to avoid scalp bruising; screen for blood‑type incompatibilities when indicated.
Complications
When bilirubin rises to very high levels, it can cross the immature blood‑brain barrier and cause neurologic injury known as kernicterus. Even modestly elevated levels, if left unchecked, may lead to:
- Acute bilirubin encephalopathy: Lethargy, hypotonia, high‑pitched cry.
- Kernicterus (chronic bilirubin encephalopathy): Permanent motor deficits, hearing loss, gaze abnormalities.
- Feeding difficulties and dehydration: Resulting from poor intake.
- Readmission: Babies who go home without adequate follow‑up may need rehospitalization for phototherapy.
According to the CDC, severe hyperbilirubinemia accounts for approximately 0.5 % of all newborn hospital readmissions in the United States.[3] CDC
When to Seek Emergency Care
- Skin or eyes become deeply yellow (especially if the yellow spreads to the abdomen, limbs, or the whole body) within the first 24 hours.
- Persistent vomiting, inability to feed, or a noticeable decrease in urine output (fewer than 4 wet diapers in 24 h).
- Extreme sleepiness, difficulty waking, or a high‑pitched, inconsolable cry.
- Stiff or floppy muscle tone, seizures, or abnormal eye movements.
- Fever ≥ 38 °C (100.4 °F) or a drop in body temperature below 36.5 °C (97.7 °F).
- Rapid weight loss > 10 % of birth weight despite feeding attempts.
These symptoms may indicate toxic levels of bilirubin or another serious condition and require immediate medical assessment.
References
- Mayo Clinic. “Jaundice in newborns.” Updated 2023. https://www.mayoclinic.org.
- American Academy of Pediatrics. “Management of Hyperbilirubinemia in the Full-Term and Near-Term Newborn.” Pediatrics, 2022. https://pediatrics.aappublications.org.
- Centers for Disease Control and Prevention. “Neonatal Jaundice & Hyperbilirubinemia.” 2022. https://www.cdc.gov.
- World Health Organization. “Neonatal Jaundice: Guidelines for the Management in Low‑Resource Settings.” 2021.
- Cleveland Clinic. “Physiologic Jaundice of the Newborn.” 2023. https://my.clevelandclinic.org.